Racheal Lee
Sep 26, 2013

Pfizer appoints Leo Burnett for flagship-brand launches in Vietnam

HO CHI MINH CITY - Pharmaceutical corporation Pfizer has named Leo Burnett Vietnam for the launch of Pfizer’s two flagship brands, Centrum and Caltrate, in the country.

Pfizer appoints Leo Burnett for flagship-brand launches in Vietnam

The appointment comes after a six-way pitch called in June. The final round of the pitch saw Leo Burnett competing against Lowe and Ogilvy & Mather.

Plans are still under development stage at the moment. David Probert, national consumer/retail development lead of Pfizer, noted that the company wants to ensure that its science-based vitamins and nutritional products will become more familiar to Vietnamese consumers and thus help to enhance their health and well-being. 

“We knew that we needed a partner who had a good understanding of this developing market and could also work across borders by leveraging much of the good work they had done already,” he said.

This is the first time Leo Burnett Vietnam has worked with the pharmaceutical company, but the network has long worked with Pfizer across the region.

Pfizer consolidated all consumer healthcare brands with Leo Burnett Shanghai in April, while it was tipped to have appointed Leo Burnett Hong Kong in February for its birth-control brand, Harmonet. In 2011, Pfizer selected Leo Burnett to handle its creative business in Taiwan.

In Indonesia, meanwhile, Pfizer is working with Y&R Indonesia for its Novarsc brand.

Lukasz Roszczyc, managing director of Leo Burnett Vietnam, said the agency aims to deliver creative solutions rooted in HumanKind thinking, backed by integrated capabilities across digital/social, content and shopper-marketing.

This new win follows the agency’s recent appointment by Vietnam Prosperity Bank to launch its new virtual prepaid card offering locally.

Source:
Campaign Asia

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

22 hours ago

BYD closes 2024 on top, but can it sustain its EV ...

BRAND HEALTH CHECK: After outpacing Tesla and smashing 2024 sales records, BYD faces its toughest road yet. With 45% EU tariffs and a locked-out U.S. market, can the EV giant supercharge global ambitions or stall under trade barriers?

22 hours ago

Move and win roundup: Week of January 2, 2025

As 2025 kicks off, Campaign rounds up the first major people moves and business wins of the year. From leadership exits to new creative wins, catch all the latest updates in January's first edition.

23 hours ago

What's in, what's out: Marketing trends you need to ...

OUTLOOK 2025: A clear, concise and constantly updated guide for industry trends and predictions—all in one place. Check back often for the freshest updates.